19 results

• Dupixent Caused T-Cell Lymphoma or Rapidly Progressed Cancer, Lawsuit Alleges

  February 25, 2026

  Irvin Jackson

  A Dupixent cancer lawsuit indicates that not only did the drug make his eczema worse, it also caused him to develop late-stage T-cell lymphoma.

• MDL Sought for Dupixent Lymphoma Lawsuits Filed in Federal Courts Nationwide

  February 19, 2026

  Irvin Jackson

  A group of plaintiffs has petitioned the U.S. Judicial Panel on Multidistrict Litigation to centralize all Dupixent lymphoma lawsuits before a single judge for coordinated pretrial proceedings, a move that could ultimately lead to bellwether trials and a global resolution of the claims.

• Lawsuit Claims Dupixent for Atopic Dermatitis, Eczema Treatment Caused CTCL

  February 10, 2026

  Irvin Jackson

  The manufacturers of Dupixent are facing a product liability lawsuit from a man who alleges the eczema drug caused him to develop a rare form of cancer.

• CTCL Diagnosis Leads to Lawsuit Over Dupixent Cancer Risks

  February 3, 2026

  Irvin Jackson

  A Dupixent cancer lawsuit indicates that manufacturers knew of the risks of CTCL, yet failed to report them to patients or doctors.

• Lawsuit Claims Dupixent Side Effects Led to CTCL Cancer Diagnosis

  January 12, 2026

  Irvin Jackson

  A Dupixent lawsuit claims that side effects of the eczema drug led to the development of a rare form of T-cell lymphoma.

• Asthma, Eczema Risks Higher for Children Conceived Through Assisted Reproduction: Study

  January 5, 2026

  Martha Garcia

  A new study finds a connection between assisted reproduction technology and immune system reactions like eczema and asthma.

• Lawsuit Alleges Dupixent Caused Cancer Diagnosis After One Year of Injections

  December 30, 2025

  Irvin Jackson

  A Dupixent lawsuit claims a woman developed T-cell lymphoma after just a year of injections, and must now receive lifelong medical monitoring.

• Dupixent Cancer Lawsuit Filed Over Cutaneous T-Cell Lymphoma (CTCL) Diagnosis

  December 19, 2025

  Irvin Jackson

  An Illinois woman diagnosed with stage IV cutaneous T-cell lymphoma (CTCL) after two years of Dupixent injections has filed a lawsuit against the drug manufacturers.

• Lawyers Propose Dupixent Lawsuit Be Set for Trial After Dec. 6, 2027

  December 11, 2025

  Irvin Jackson

  Parties in a Dupixent wrongful death lawsuit met with the presiding judge for the first time this week, indicating the case will be ready for trial by December 6, 2027.

• Dupixent CTCL Lawsuit Filed Over Diagnosis of Both Mycosis Fungoides and Sezary Syndrome

  December 5, 2025

  Irvin Jackson

  A Louisiana man was diagnosed with two rare forms of T-cell lymphoma after receiving Dupixent injections for less than two years.